Cargando…

Quinacrine Treatment of Nitroimidazole-Refractory Giardiasis

BACKGROUND: Limited evidence exists on efficacy and tolerability of quinacrine for nitroimidazole-refractory giardiasis. METHODS: Nitroimidazole-refractory giardiasis cases, defined as microbiologically (microscopy and/or PCR) confirmed treatment failure after 2 courses, during 2008–2020, were retro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ydsten, Karin A, Hellgren, Urban, Asgeirsson, Hilmir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Major Articles and Brief Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9113433/ https://www.ncbi.nlm.nih.gov/pubmed/34036328 http://dx.doi.org/10.1093/infdis/jiab287

Ejemplares similares

1408. Epidemiology of Nitroimidazole-refractory Giardiasis
por: Ydsten, Karin, et al.
Publicado: (2023)

Treatment of Giardiasis after Nonresponse to Nitroimidazole
por: Meltzer, Eyal, et al.
Publicado: (2014)

Efficacy of 5-Nitroimidazoles for the Treatment of Giardiasis: A Systematic Review of Randomized Controlled Trials
por: Pasupuleti, Vinay, et al.
Publicado: (2014)

Treatment-refractory giardiasis: challenges and solutions
por: Lalle, Marco, et al.
Publicado: (2018)

Click chemistry-facilitated comprehensive identification of proteins adducted by antimicrobial 5-nitroimidazoles for discovery of alternative drug targets against giardiasis
por: Lauwaet, Tineke, et al.
Publicado: (2020)

Refractory giardiasis in a child with steroid-resistant nephrotic syndrome
por: Kalita, Jitu Mani, et al.
Publicado: (2023)

Quinacrine Induces Nucleolar Stress in Treatment-Refractory Ovarian Cancer Cell Lines
por: Oien, Derek B., et al.
Publicado: (2021)

Treatment of Oriental Sore with Quinacrine
por: Sachdeva, Y. V.
Publicado: (1943)

Evaluation of a pneumonia multiplex PCR panel for detection of bacterial respiratory tract pathogens from serial specimens collected from hospitalized COVID-19 patients
por: Tellapragada, Chaitanya, et al.
Publicado: (2022)

Pharmacokinetics of quinacrine in the treatment of prion disease
por: Yung, Lotus, et al.
Publicado: (2004)

Giardiasis
por: Treu, Rudolf
Publicado: (1944)

Toxic Symptoms Associated with Quinacrine Treatment
por: Nandi, D. K.
Publicado: (1947)

Successful treatment of 2 imported cases of Mansonella perstans infection
por: Asgeirsson, Hilmir, et al.
Publicado: (2017)

Diffuse Nodular Lymphoid Hyperplasia of the Intestine Caused by Common Variable Immunodeficiency and Refractory Giardiasis
por: Choi, Jung Hye, et al.
Publicado: (2017)

Parenteral Quinacrine in Malarial Fevers
por: Basumullick, K. L., et al.
Publicado: (1947)

Giardiasis in Children
por: Mohapatra, G. S.
Publicado: (1948)

Enhancement of paclitaxel activity against hormone-refractory prostate cancer cells in vitro and in vivo by quinacrine.
por: de Souza, P. L., et al.
Publicado: (1997)

Low mortality but increasing incidence of Staphylococcus aureus endocarditis in people who inject drugs: Experience from a Swedish referral hospital
por: Asgeirsson, Hilmir, et al.
Publicado: (2016)

Quinacrine in the Eradication of Giardia Lamblia Infection
por: Pant, K. C., et al.
Publicado: (1942)

Intestinal Giardiasis Disguised as Ulcerative Colitis
por: Zhen, Yu, et al.
Publicado: (2018)

A Case of Giardiasis
por: Simeons, A. T. W.
Publicado: (1942)

Chemosensitization by lipophilic nitroimidazoles.
por: Twentyman, P. R., et al.
Publicado: (1983)

Recent Antimalarials in Giardiasis
por: Poddar, J., et al.
Publicado: (1954)

Disease Biomarkers of Giardiasis
por: Roshidi, Norhamizah, et al.
Publicado: (2022)

Continuous Quinacrine Treatment Results in the Formation of Drug-Resistant Prions
por: Ghaemmaghami, Sina, et al.
Publicado: (2009)

A Case of Giardiasis
por: Andleigh, H. S.
Publicado: (1942)

Quinacrine, an Old Drug with Potentially usefull in the Treatment for COVID-19
por: PINEDA, BENJAMIN
Publicado: (2021)

Repurposing Pyramax®, quinacrine and tilorone as treatments for Ebola virus disease
por: Lane, Thomas R., et al.
Publicado: (2020)

Giardiasis Outbreaks — United States, 2012–2017
por: Conners, Erin E., et al.
Publicado: (2021)

Transition to PCR diagnosis of cryptosporidiosis and giardiasis in the Norwegian healthcare system: could the increase in reported cases be due to higher sensitivity or a change in the testing algorithm?
por: Campbell, Sophie M., et al.
Publicado: (2022)

Incidental Diagnosis of Duodenal Giardiasis
por: Kalas, M Ammar, et al.
Publicado: (2021)

Repurposing Quinacrine for Treatment of Malignant Mesothelioma: In-Vitro Therapeutic and Mechanistic Evaluation
por: Kulkarni, Nishant S., et al.
Publicado: (2020)

Giardiasis—A Definite Disease
por: Bhattacharjea, T.
Publicado: (1943)

A Note on Giardiasis with Steatorrhœa
por: Chaudhuri, R. N.
Publicado: (1943)

Multilevel Approach for the Treatment of Giardiasis by Targeting Arginine Deiminase
por: Fernández-Lainez, Cynthia, et al.
Publicado: (2021)

The Role of Nitroreductases in Resistance to Nitroimidazoles
por: Thomas, Carol, et al.
Publicado: (2021)

Second U.K. workshop on the enhancement of chemotherapy by nitroimidazoles
Publicado: (1983)

Giardiasis—Two Case Reports
por: Gupta, D. N. Sen
Publicado: (1942)

First case of community acquired giardiasis in Nuuk, Greenland
por: Thomas, Astrid, et al.
Publicado: (2021)

Two Cases Showing Cerebral Symptoms after Treatment with Quinacrine for Malaria
por: Berry, J. N.
Publicado: (1945)

Cannot write session to /tmp/vufind_sessions/sess_tpmco4o1n3nfltm107vk4tr6g4